Dual Antiplatelet Therapy Versus Oral Anticoagulation for a Short Time to Prevent Cerebral Embolism After TAVI "AUREA"

Recruiting

Phase 4 Results N/A

Summary of Purpose

The purpose of this study is to determine the incidence of major vascular events (ischemic or haemorrhagics) at the third month after initiation of the antithrombotic treatment (oral anticoagulation or dual antiplatelet therapy) in both arms followed TAVI.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 2 June 2017.

1 Apr 2013 19 Jun 2012 1 Dec 2017 1 Jun 2018 1 Jun 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Single Blind (Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

See All